Agrawal Rupesh, Gupta Bhaskar, González-López Julio J, Cardoso João, Triantafullopoulou Ioanna, Grant Robert, Addison Peter K F, Westcott Mark, Pavesio Carlos E
a Moorfields Eye Hospital , NHS Foundation Trust , London , UK.
b Biomedical Research Centre , UCL Institute of Ophthalmology , London , UK.
Ocul Immunol Inflamm. 2017 Feb;25(1):97-104. doi: 10.3109/09273948.2015.1087577. Epub 2016 Jan 25.
To describe the clinical spectrum and outcome of patients with presumed tubercular uveitis and choroidal involvement.
A retrospective case series nested in a cohort study was enrolled at a tertiary referral eye care center in the UK. Failure was defined as recurrence of lesion within 6 months of completion of antitubercular therapy (ATT) or corticosteroid therapy.
Seventy-seven patients with presumed ocular tuberculosis and choroidal involvement were included in the study. Mean age was 45.5 ± 15.7 years, 44 (57.1%) patients were male, and 51 (66.2%) presented with bilateral disease. Choroidal granuloma was the most frequent clinical presentation (n = 27, 35.07%), followed by multifocal choroiditis (n = 24, 31.17%) and serpiginous-like choroiditis (n = 18, 23.38%). Quantiferon Gold in Tube Test (QFT) was positive in 64 (83.11%) patients. Fifty (64.94%) patients received ATT.
Choroidal involvement in presumed ocular tuberculosis can present with a variable spectrum. Treatment failure rates were equivalent between ATT and non-ATT treated groups.
描述疑似结核性葡萄膜炎并累及脉络膜患者的临床特征及预后。
在英国一家三级转诊眼科护理中心进行一项嵌套于队列研究中的回顾性病例系列研究。治疗失败定义为抗结核治疗(ATT)或糖皮质激素治疗结束后6个月内病变复发。
77例疑似眼部结核并累及脉络膜的患者纳入研究。平均年龄为45.5±15.7岁,44例(57.1%)为男性,51例(66.2%)表现为双侧病变。脉络膜肉芽肿是最常见的临床表现(n = 27,35.07%),其次是多灶性脉络膜炎(n = 24,31.17%)和匐行性脉络膜炎样病变(n = 18,23.38%)。64例(83.11%)患者的全血γ-干扰素释放试验(QFT)呈阳性。50例(64.94%)患者接受了抗结核治疗。
疑似眼部结核累及脉络膜时可表现出多种临床特征。抗结核治疗组和未接受抗结核治疗组的治疗失败率相当。